newsfilter
← Latest News
GlobeNewswire·

Repligen Corporation to Present at J.P. Morgan 2026 Healthcare Conference

  • Repligen Corporation (NASDAQ: RGEN) will participate in the J.P. Morgan 2026 Healthcare Conference held January 12–15 in San Francisco.
  • CEO Olivier Loeillot will present an overview of the company on Tuesday, January 13 at 2:15 p.m. PT.
  • A live webcast of the presentation will be available on Repligen's Investor Relations website at www.repligen.com with a limited-time replay.
  • Repligen develops bioprocessing technologies for biopharmaceutical drug developers & CDMOs across filtration, chromatography, process analytics, & proteins.
  • The company's headquarters are in Waltham, Massachusetts, with manufacturing sites in the U.S. as well as Estonia, France, Germany, Ireland, the Netherlands, & Sweden.